1-5 of 5
Josée M. Zijlstra
Close
Sort by
Journal Articles

Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: a propensity score–matched analysis

Clinical Trials & Observations
Julia Driessen, Fer de Wit, Alex F. Herrera, Pier Luigi Zinzani, Ann S. LaCasce, Peter D. Cole, Craig H. Moskowitz, Ramón García-Sanz, Michael Fuchs, Horst Müller, Peter Borchmann, Armando Santoro, Heiko Schöder, Josée M. Zijlstra, Barbara A. Hutten, Alison J. Moskowitz, Marie José Kersten
Journal: Blood Advances
Blood Adv (2024) 8 (11): 2740–2752.
https://doi.org/10.1182/bloodadvances.2023012145
Published: 2024
Includes: Supplemental data
Journal Articles

Prognostic model using 18 F-FDG PET radiomics predicts progression-free survival in relapsed/refractory Hodgkin lymphoma

Julia Driessen, Gerben J. C. Zwezerijnen, Heiko Schöder, Marie José Kersten, Alison J. Moskowitz, Craig H. Moskowitz, Jakoba J. Eertink, Martijn W. Heymans, Ronald Boellaard, Josée M. Zijlstra
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6732–6743.
https://doi.org/10.1182/bloodadvances.2023010404
Published: 2023
Includes: Supplemental data
Journal Articles

No sex differential in relative survival among older patients with DLBCL treated with R-CHOP21: a population-based study

Emma E. Geerdes, Müjde Durmaz, Pieternella J. Lugtenburg, Martine E. D. Chamuleau, Otto Visser, Djamila E. Issa, Rolf E. Brouwer, Eduardus F. M. Posthuma, Josée M. Zijlstra, Marie José Kersten, Avinash G. Dinmohamed
Journal: Blood Advances
Blood Adv (2023) 7 (17): 4869–4873.
https://doi.org/10.1182/bloodadvances.2023010480
Published: 2023
Includes: Supplemental data
Journal Articles

Baseline radiomics features and MYC rearrangement status predict progression in aggressive B-cell lymphoma

Clinical Trials & Observations
Jakoba J. Eertink, Gerben J. C. Zwezerijnen, Sanne E. Wiegers, Simone Pieplenbosch, Martine E. D. Chamuleau, Pieternella J. Lugtenburg, Daphne de Jong, Bauke Ylstra, Matias Mendeville, Ulrich Dührsen, Christine Hanoun, Andreas Hüttmann, Julia Richter, Wolfram Klapper, Yvonne W. S. Jauw, Otto S. Hoekstra, Henrica C. W. de Vet, Ronald Boellaard, Josée M. Zijlstra
Journal: Blood Advances
Blood Adv (2023) 7 (2): 214–223.
https://doi.org/10.1182/bloodadvances.2022008629
Published: 2023
Includes: Supplemental data
Journal Articles

Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: a Dutch population-based study

Clinical Trials & Observations
Mirian Brink, Xaver U. Kahle, Joost S. P. Vermaat, Josee M. Zijlstra, Martine Chamuleau, Marie José Kersten, Müjde Durmaz, Wouter J. Plattel, Pieternella J. Lugtenburg, Wendy Stevens, Rogier Mous, Elisabeth G. E. de Vries, Marjolein W. M. van der Poel, Prashant V. Nannan Panday, Gerwin Huls, Tom van Meerten, Marcel Nijland
Journal: Blood Advances
Blood Adv (2021) 5 (15): 2958–2964.
https://doi.org/10.1182/bloodadvances.2021004295
Published: 2021
Includes: Supplemental data